Doctor profile · Federal record
Dr. Adam Standiford, PA-C
Physician Assistant · Portage, MI
- NPI 1932731999
- Accepts Medicare
- MIPS 83.6 / 100 · 2023
- 7 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3000 Old Centre RD
Portage, MI 490244883
(269) 321-7546
fax (269) 321-1705
Credentials & registration
- NPI registered
- February 2020 — 6 yrs on file
- Year of graduation
- 2019 — 7 yrs since
- Specialty taxonomy
- 363A00000X — NUCC code
- State license (1)
- Michigan #5601009869
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1932731999. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,118
Distinct HCPCS
10
Medicare allowed
$122,099
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,302 | 254 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 619 | 514 | $72 | |
17000 |
Destruction of precancer skin growth, 1 growth | 396 | 325 | $43 | |
11102 |
Biopsy of related skin growth, first growth | 177 | 169 | $73 | |
17110 |
Destruction of skin growth, 1-14 growths | 176 | 162 | $89 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 128 | 26 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 79 | 62 | $104 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 72 | 72 | $91 | |
11103 |
Biopsy of related skin growth, each additional growth | 55 | 41 | $40 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 33 | 31 | $46 |
In context: peer comparison
Among 10 peers in this city , average services per provider: 164. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$2,213
Transactions
87
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $281.59 | |
| ABBVIE INC. | 14 | $277.26 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $231.88 | |
| UCB, Inc. | 5 | $185.62 | |
| GENZYME CORPORATION | 5 | $123.78 | |
| Lilly USA, LLC | 6 | $123.65 | |
| Incyte Corporation | 4 | $108.27 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $106.76 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $100.50 | |
| Arcutis Biotherapeutics, Inc. | 5 | $89.52 | |
| LEO Pharma Inc. | 4 | $86.92 | |
| Janssen Biotech, Inc. | 4 | $85.52 | |
| Fresenius Kabi USA, LLC | 2 | $67.98 | |
| Novartis Pharmaceuticals Corporation | 4 | $63.44 | |
| Dermavant Sciences, Inc. | 4 | $63.23 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
939
Patients
653
Total drug cost
$50,624
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Fluorouracil | Generic | 187 | 167 | $15,808 |
| Clobetasol Propionate | Generic | 140 | 88 | $7,724 |
| Triamcinolone Acetonide | Generic | 140 | 96 | $1,819 |
| Ketoconazole | Generic | 116 | 76 | $3,313 |
| Ciclopirox | Generic | 43 | 22 | $1,873 |
| Tacrolimus | Generic | 42 | 25 | $8,545 |
| Desonide | Generic | 39 | 34 | $2,446 |
| Metronidazole | Generic | 36 | 30 | $2,060 |
| Imiquimod | Generic | 32 | 27 | $1,146 |
| Doxycycline Hyclate | Generic | 31 | 17 | $1,045 |
Hospital affiliations
Frequently asked questions
What is Dr. Adam Standiford's medical specialty?
Dr. Adam Standiford practices Physician Assistant in Portage, MI.
Where does Dr. Adam Standiford practice?
Dr. Adam Standiford practices at 3000 Old Centre RD, Portage, MI 490244883. Office phone: 2693217546.
What is Dr. Adam Standiford's NPI?
Dr. Adam Standiford's National Provider Identifier (NPI) is 1932731999, issued by NPPES.
Does Dr. Adam Standiford accept Medicare assignment?
Yes. Dr. Adam Standiford accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Adam Standiford commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.